BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31246553)

  • 21. Mixed-methods approach to evaluate an mHealth intervention to increase adherence to triage of human papillomavirus-positive women who have performed self-collection (the ATICA study): study protocol for a hybrid type I cluster randomized effectiveness-implementation trial.
    Arrossi S; Paolino M; Orellana L; Thouyaret L; Kohler RE; Viswanath K
    Trials; 2019 Feb; 20(1):148. PubMed ID: 30808379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study.
    Olwanda E; Shen J; Kahn JG; Bryant-Comstock K; Huchko MJ
    Glob Health Action; 2018; 11(1):1451455. PubMed ID: 29589991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
    Lam JU; Rebolj M; Møller Ejegod D; Pedersen H; Rygaard C; Lynge E; Thirstrup Thomsen L; Krüger Kjaer S; Bonde J
    Int J Cancer; 2017 May; 140(10):2212-2219. PubMed ID: 28195317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
    Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
    BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Message Framing on Cervical Cancer Screening Knowledge and Intentions Related to Primary HPV Testing.
    Ogden SN; Leskinen EA; Sarma EA; Wainwright JV; Rendle KA
    Cancer Prev Res (Phila); 2021 Sep; 14(9):839-844. PubMed ID: 33846214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
    BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge and Attitudes of Bangkok Metropolitan Women towards HPV and Self-Sampled HPV Testing.
    Kittisiam T; Tangjitgamol S; Chaowawanit W; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(5):2445-51. PubMed ID: 27268612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
    Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
    LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study.
    Page CM; Ibrahim S; Park LP; Huchko MJ
    PLoS One; 2019; 14(9):e0222750. PubMed ID: 31532808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
    Stuart A; Obiri-Yeboah D; Adu-Sarkodie Y; Hayfron-Benjamin A; Akorsu AD; Mayaud P
    BMC Womens Health; 2019 Oct; 19(1):123. PubMed ID: 31647013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels.
    Williams MS; Kenu E; Adanu A; Yalley RA; Lawoe NK; Dotse AS; Adu RF; Fontaine K
    J Cancer Educ; 2019 Oct; 34(5):897-903. PubMed ID: 29974412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
    Sasaki Y; Iwanari O; Arakawa I; Moriya T; Mikami Y; Iihara K; Konno R
    Int J Gynecol Cancer; 2017 Mar; 27(3):523-529. PubMed ID: 27997455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
    Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
    Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
    Shen J; Olwanda E; Kahn JG; Huchko MJ
    BMC Health Serv Res; 2018 May; 18(1):378. PubMed ID: 29801496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
    Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
    Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
    Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
    Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring women's preferences for HPV-based cervical cancer screening in South Africa.
    Oberlin AM; Pasipamire T; Chibwesha CJ
    Int J Gynaecol Obstet; 2019 Aug; 146(2):192-199. PubMed ID: 31127861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.